Mortality of SARS-CoV-2 Infection in Patients With Fibrotic Interstitial Lung Disease

MLA

K. Donohoe, et al. “Mortality of SARS-CoV-2 Infection in Patients With Fibrotic Interstitial Lung Disease.” B40. POTPOURRI IN ILD: SPANNING THE SPECTRUM FROM RARE TO COMMON LUNG DISEASES, May 2023. EBSCOhost, https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3280.

APA

K. Donohoe, E. Karlsen, A.W. Wong, B. Min, C. Durand, K.A.M. Johannson, S.D. Lok, H. Manganas, V. Marcoux, J. Morisset, & C.J. Ryerson. (2023). Mortality of SARS-CoV-2 Infection in Patients With Fibrotic Interstitial Lung Disease. B40. POTPOURRI IN ILD: SPANNING THE SPECTRUM FROM RARE TO COMMON LUNG DISEASES. https://doi.org/10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3280

Chicago

K. Donohoe, E. Karlsen, A.W. Wong, B. Min, C. Durand, K.A.M. Johannson, S.D. Lok, et al. 2023. “Mortality of SARS-CoV-2 Infection in Patients With Fibrotic Interstitial Lung Disease.” B40. POTPOURRI IN ILD: SPANNING THE SPECTRUM FROM RARE TO COMMON LUNG DISEASES, May. doi:10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a3280.